Icahn: Time to change Genzyme's old guard
This article was originally published in Scrip
Executive Summary
Activist investor Carl Icahn and his fellow nominees to Genzyme's board have published a damning report of the company's current woes and have once again urged shareholders to help fix the "broken" firm.